p53 codon 72 polymorphisms in human papillomavirus-negative and human papillomavirus-positive squamous cell carcinomas of the oropharynx

Cancer

Volumn 109, Issue 12, 2007, Pages 2461-2465

  Perrone, Federica ^a   Mariani, Luigi ^a   Pastore, Elisa ^a   Orsenigo, Marta ^a   Suardi, Simona ^a   Marcomini, Barbara ^a   DaRiva, Luca ^a   Licitra, Lisa ^a   Carbone, Antonino ^a   Pierotti, Marco A ^a,b   Pilotti, Silvana ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

Cancer risk; High risk human papillomavirus (HR HPV) positive; Oropharyngeal squamous cell carcinoma; p53 polymorphism

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ADULT; AGED; ALCOHOL ABUSE; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; SMOKING; SQUAMOUS CELL CARCINOMA; WART VIRUS;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CODON; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34250208777     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22702     Document Type: Article

References (23)

1. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol. 2004;31:744-754.
2. Licitra L, Perrone F, Bossi P et al. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006;24:5630-5636.
3. Perrone F, Suardi S, Pastore E, et al. Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2006;12:6643-6651.
4. Pim D, Banks L. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer. 2004;108:196-199.
5. Dumont P, Leu JI, Della Pietra AC 3rd, Gorge DL, Murphy M. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357-365.
6. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092-1100.
7. Drummond SN, De Marco L, Pordeus Ide A, Barbosa AA, Gomez RS. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res. 2002;22:3379-3381.
8. Hamel N, Black MJ, Ghadirian P, Foulkes WD. No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer. 2000;82:757-759.
9. McWilliams JE, Evans A, Beer TM, et al. Genetic polymorphisms in head and neck cancer risk. Head Neck. 2000;22:609-617.
10. Cortezzi SS, Provazzi PJ, Sobrinho JS, et al. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer Genet Cytogenet. 2004;150:44-49.
11. Summersgill KF, Smith EM, Kirchner L, Haugen TH, Turek LP. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:334-339.
12. Shen H, Zheng Y, Sturgis EM, Spitz MR, Wei Q. p53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett. 2002;183:123-130.
13. Scheckenbach K, Lieven O, Gotte K, et al. p53 codon 72 polymorphic variants, loss of allele-specific transcription, and human papilloma virus 16 and/or 18 E6 messenger RNA expression in squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev. 2004;13:1805-1809.
14. Storey A, Thomas M, Kalita A, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature. 1998;393:229-234.
15. Nagpal JK, Patnaik S, Das BR. Prevalence of high-risk human papillomavirus types and its association with p53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer. 2002;97:649-653.
16. Katiyar S, Thelma BK, Murthy NS, et al. Polymorphism of the p53 codon 72 Arg/pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem. 2003;252:117-124.
17. Beckman G, Birgander R, Sjalander A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered. 1994;44:266-270.
18. Perrone F, Oggionni M, Birindelli S, et al. TP53, p14ARF, p16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Int J Cancer. 2003;105:196-203.
19. Granja F, Morari J, Morari EC, Correa LAC, Assumpcao LVM, Ward LS. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer. Cancer Lett. 2004;210;151-157.
20. Tsai MH, Lin CD, Hsieh YY, et al. Prognostic significance of the proline form of p53 codon 72 polymorphism in nasopharyngeal carcinoma. Laryngoscope. 2002;112:116-119.
21. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. P53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res. 1999;1:129-134.
22. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene. 1995;10:927-936.
23. Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene. 1999;18:2381-2386.